Fractional exhaled nitric oxide and induced sputum

Area of Science:

• Pulmonology
• Allergy and Immunology
• Biomarkers

Background:

• Asthma management traditionally relies on symptoms and lung function tests.
• Non-invasive markers of airway inflammation are increasingly important for personalized treatment.
• Current methods require safe, accurate, and reproducible assessment tools.

Purpose of the Study:

• To evaluate the utility of fractional exhaled nitric oxide (FeNO) and induced sputum as non-invasive markers of airway inflammation in asthma.
• To compare these methods with conventional asthma assessment tools like spirometry and bronchial hyperresponsiveness (BHR) testing.

Main Methods:

• Review of current literature on FeNO and induced sputum measurements in asthma.
• Analysis of the advantages and limitations of each method.
• Comparison of FeNO and sputum analysis with spirometry and BHR.

Main Results:

• FeNO is non-invasive, safe, and reproducible, but cut-off values and interpretation require further clarification.
• Induced sputum provides direct inflammatory information (e.g., eosinophils) but is more labor-intensive.
• Both FeNO and induced sputum offer complementary data to conventional asthma diagnostics.

Conclusions:

• FeNO and induced sputum are valuable additions to conventional asthma assessment.
• These non-invasive markers aid in understanding and managing airway inflammation.
• Further research is needed to optimize the clinical application and interpretation of these biomarkers.